Your session is about to expire
← Back to Search
Behavioral Intervention
BeatIt-ASD for Autism Spectrum Disorder
N/A
Waitlist Available
Led By Vanessa H Bal, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to adapt the BeatIt program for autistic adults, including those with intellectual disabilities. The program helps improve mood by getting participants involved in meaningful activities. Researchers will see if this adapted program can help reduce depression in this group. The Beatalk technique, which uses beatbox sounds and rhythms to improve speech, has been tested as a new method for adults with intellectual disabilities.
Eligible Conditions
- Autism Spectrum Disorder
- Schizophrenia
- Depression
- Autism
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 (initial assessment) to week 16 (outcome) to week 22 (follow-up)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in behavioral activation on Behavioral Activation for Depression Scale (BADS)
Change in distress on Anxiety Depression and Mood Scale (ADAMS)
Change in distress on Glasgow Depression Scale (GDS)
+5 moreSecondary study objectives
Change in adaptive behavior on Vineland Adaptive Behavior Scale, 3rd edition (VABS-3)
Change in quality of life on Shalock Quality of Life Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Intervention GroupExperimental Treatment1 Intervention
Participants, along with a support person, will complete 12 weekly sessions of the BeatIt-ASD intervention. The support person will complete an initial session before commencement of the 12 weekly sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BeatIt-ASD
2021
N/A
~20
Find a Location
Who is running the clinical trial?
Governor's Council for Medical Research and Treatment of AutismUNKNOWN
Rutgers, The State University of New JerseyLead Sponsor
448 Previous Clinical Trials
66,666 Total Patients Enrolled
9 Trials studying Autism Spectrum Disorder
164 Patients Enrolled for Autism Spectrum Disorder
Vanessa H Bal, PhDPrincipal InvestigatorRutgers University - New Brunswick
1 Previous Clinical Trials
19 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
19 Patients Enrolled for Autism Spectrum Disorder
Share this study with friends
Copy Link
Messenger